Sort   by:  
 Page size 
UnknownUnlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity.
Not available
S-EPMC3980740 | biostudies-literature
UnknownAll-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action.
Not available
S-EPMC5935706 | biostudies-literature
UnknownCost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin.
Not available
S-EPMC4374077 | biostudies-literature
UnknownIncretin therapy for type 2 diabetes in Spain: a cost-effectiveness analysis of liraglutide versus sitagliptin.
Not available
S-EPMC3889333 | biostudies-literature
UnknownPrognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations.
Not available
S-EPMC8852707 | biostudies-literature
UnknownThe FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.
Not available
S-EPMC11393969 | biostudies-literature
UnknownTransformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Not available
S-EPMC12481261 | biostudies-literature
UnknownDeterminants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Not available
S-EPMC11795382 | biostudies-literature
Sort   by:  
 Page size